CERS Q4 2019 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$335M

Q4 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$21M+26.6% YoY

Gross Profit

$12M55.6% margin

Operating Income

-$16M-78.4% margin

Net Income

-$17M-80.9% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+16.1%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$166M

Total Liabilities

$108M

Stockholders' Equity

$57M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$17M	+26.6%
Gross Profit	$12M	$8M	+43.8%
Operating Income	-$16M	-$15M	-6.1%
Net Income	-$17M	-$16M	-4.4%

Revenue Segments

Government Contract

$6M100%

Geographic Segments

Europe Middle East And Africa

$14M68%

North America

$6M31%

Other

$190,0001%